Athena Athena

X

Digital content for Lynk Pharmaceuticals

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Lynk Pharmaceuticals
China Flag
Country
Country
China
Address
Address
291 Fucheng Road, Bldg 5-402, Jianggan, Hangzhou, Zhejiang 310018, China
Telephone
Telephone
+86 0571-87711179
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announced-first-rheumatoid-arthritis-patient-dosed-in-phase--clinical-study-of-lnk01001-302019129.html

PR NEWSWIRE
20 Dec 2023

https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-completes-series-c2-financing-round-with-total-c-round-funding-of-322-million-rmb-301933690.html

PR NEWSWIRE
21 Sep 2023

https://www.fiercebiotech.com/biotech/lynk-brushing-eqrx-rejection-hits-main-goal-wrap-clean-sweep-phase-2-jak-trials

Nick Paul Taylor FIERCE BIOTECH
23 Aug 2023

https://www.fiercebiotech.com/biotech/after-eqrx-partnership-falls-apart-lynks-mid-stage-eczema-trial-hits-main-goals

Gabrielle Masson FIERCE BIOTECH
09 Aug 2023

https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announced-positive-topline-data-from-phase-ii-clinical-trial-of-lnk01001-in-the-treatment-of-atopic-dermatitis-301895890.html

PR NEWSWIRE
09 Aug 2023

https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announces-first-atopic-dermatitis-patient-dosed-with-lnk01004-in-phase-ib-clinical-study-301882254.html

PR NEWSWIRE
21 Jul 2023

https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-completes-200-million-rmb-series-c1-financing-to-accelerate-clinical-development-of-core-products-301837939.html

PR NEWSWIRE
31 May 2023

https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announces-first-cohort-of-psoriatic-patients-dosed-with-lnk01004-in-phase-ib-clinical-study-301834096.html

PR NEWSWIRE
25 May 2023

https://www.clinicaltrialsarena.com/news/lynk-first-cohort-psoriasis-therapy/

CLINICAL TRIALS ARENA
25 May 2023

https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announces-positive-results-for-lnk01003-in-phase-i-trial-in-healthy-subjects-301788958.html

PR NEWSWIRE
04 Apr 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY